Your browser doesn't support javascript.
loading
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
Siegel, Jacob; Totonchy, Mariam; Damsky, William; Berk-Krauss, Juliana; Castiglione, Frank; Sznol, Mario; Petrylak, Daniel P; Fischbach, Neal; Goldberg, Sarah B; Decker, Roy H; Stamatouli, Angeliki M; Hafez, Navid; Glusac, Earl J; Tomayko, Mary M; Leventhal, Jonathan S.
Afiliação
  • Siegel J; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
  • Totonchy M; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
  • Damsky W; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
  • Berk-Krauss J; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
  • Castiglione F; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
  • Sznol M; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.
  • Petrylak DP; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut; Department of Urology, Yale University School of Medicine, New Haven, Connecticut.
  • Fischbach N; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.
  • Goldberg SB; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.
  • Decker RH; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut.
  • Stamatouli AM; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.
  • Hafez N; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.
  • Glusac EJ; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
  • Tomayko MM; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
  • Leventhal JS; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: jonathan.leventhal@yale.edu.
J Am Acad Dermatol ; 79(6): 1081-1088, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30025829
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Dermatopatias Vesiculobolhosas / Toxidermias / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Proteínas de Neoplasias / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Dermatopatias Vesiculobolhosas / Toxidermias / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Proteínas de Neoplasias / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2018 Tipo de documento: Article